Delivery Order SPE2DB20D1110-SPE2DB25FK33J
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xtampza ER 36 mg capsules (100-count units) with a ceiling value of $8,590.87. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitively awarded contract with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the...
- The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,344.17 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Xtampza ER 36 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 16, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Xtampza ER 13.5 mg capsules (100-count units) with a ceiling value of $2,302.80. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The ultimate completion date is July 23, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,703.99 to AmerisourceBergen Drug Corp for 100 capsules of Xtampza ER 36 mg, a long-acting opioid pain medication. The contract was competitively awarded with no set-aside designation, utilizing firm fixed pricing under a delivery order contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,538.92 to AmerisourceBergen Drug Corp for XTAMPZA ER 36 mg capsules (100 count), with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete openly for federal medical procurement requirements....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Xtampza ER 18 mg capsules (100-count units) with a ceiling value of $5,707.86. This firm fixed-price delivery order, with an ultimate completion date of July 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made without a...
- The Defense Logistics Agency awarded a $2,319.51 delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 18 mg capsules (100-count units) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for 36mg Xtampza ER capsules valued at $6,176.76 on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for the federal military healthcare system. The vendor, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,141.74 for XTAMPZA ER 13.5 mg capsules (100 count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK33JDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,076.69 to AmerisourceBergen Drug Corp for Xtampza ER 36 mg capsules (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pain management pharmaceutical supply for military and federal healthcare systems. The contract includes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare programs worldwide. The DLA Troop Support Medical contract demonstrates AmerisourceBergen's critical role as a primary pharmaceutical distributor for Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers, with delivery orders ranging significantly in value to address diverse medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/8/25 |